Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Patrick Maschmeyer

2PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 30, 2025

Clonally expanded effector CD4<sup>+</sup> cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy.

Ambre Manon Giguelay, Patrick Maschmeyer, Leonie Müller-Jensen

|Dec 09, 2020

Antigen-driven PD-1<sup>+</sup> TOX<sup>+</sup> BHLHE40<sup>+</sup> and PD-1<sup>+</sup> TOX<sup>+</sup> EOMES<sup>+</sup> T lymphocytes regulate juvenile idiopathic arthritis in situ.

Patrick Maschmeyer, Gitta Anne Heinz, Christopher Mark Skopnik

Pageof 1

Frequent Collaborators

1 joint publications

Gitta Anne Heinz

1 joint publications

Christopher Mark Skopnik

1 joint publications

Andreas Radbruch

1 joint publications

Mir-Farzin Mashreghi

1 joint publications

Ambre Manon Giguelay

1 joint publications

Leonie Müller-Jensen

1 joint publications

Manpreet Meyer

1 joint publications

Petra Huehnchen

1 joint publications

Wolfgang Boehmerle

1 joint publications

Matthias Endres

Frequent Collaborators

1 joint publications

Gitta Anne Heinz

1 joint publications

Christopher Mark Skopnik

1 joint publications

Andreas Radbruch

1 joint publications

Mir-Farzin Mashreghi

Top Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on : May 27, 2011

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on : Nov 08, 2016

See more related videos

Top Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on : May 27, 2011

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on : Nov 08, 2016

See more related videos